Plante Moran Financial Advisors’s TG Therapeutics TGTX Stock Holding History

Plante Moran Financial Advisors’s Portfolio TGTX Stock Details TGTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.48K	Buy	+27	New	+$1.1K	﹤0.01%	802
2018 Q2	–	Sell	-77	Closed	-$1K	–	966
2018 Q1	$1K	Buy	+77	New	+$984	﹤0.01%	918
2017 Q1	–	Sell	-52	Closed	–	–	1020
2016 Q4	$0	Hold	52	–	–	﹤0.01%	1035
2016 Q3	$0	Hold	52	–	–	﹤0.01%	988
2016 Q2	$0	Hold	52	–	–	﹤0.01%	937
2016 Q1	$0	Buy	+52	New	+$455	﹤0.01%	1028

Other funds holding TGTX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Plante Moran Financial Advisors's TGTX Position: Q2 2026 in Review

Plante Moran Financial Advisors opened a new position in TG Therapeutics (TGTX) in Q2 2026: 27 shares worth $1.48K. The stake represents ﹤0.01% of the portfolio and ranks #802 among its holdings. This is a return to the name: Plante Moran Financial Advisors previously reported a position in TGTX as recently as Q1 2018.

Plante Moran Financial Advisors first reported a position in TGTX in Q1 2016 and has held it in 6 quarters since. 428 funds tracked by Wall St. Rank hold TGTX as of Q2 2026.

Plante Moran Financial Advisors held 27 shares of TG Therapeutics worth $1.48K as of Q2 2026.
TG Therapeutics was a new Plante Moran Financial Advisors position in Q2 2026.
TG Therapeutics made up ﹤0.01% of Plante Moran Financial Advisors's portfolio in Q2 2026, its #802 holding.
Plante Moran Financial Advisors first reported a position in TG Therapeutics in Q1 2016 and has held it in 6 quarters since.
428 funds tracked by Wall St. Rank held TG Therapeutics as of Q2 2026.

Based on Plante Moran Financial Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.